NASAL- oxymetazoline hydrochloride spray 
Bi-Mart

----------

NASAL SPRAY

Drug Facts

Active ingredient

Oxymetazoline hydrochloride 0.05%

Purpose

Nasal decongestant

Uses

Warnings

Ask a doctor before use if you have

  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland

When using this product

  • do not use more than directed
  • do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
  • temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
  • use of this container by more than one person may spread infection

Stop use and ask a doctor ifsymptoms persist.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

benzalkonium chloride solution, dibasic sodium phosphate, edetate disodium dihydrate, monobasic sodium phosphate, polyethylene glycol, povidone, propylene glycol, purified water.

Questions?

call toll-free 1-800-935-6737

Distributed by:

BI-MART

Eugene, OR 97402

*This product is not manufactured or distributed by the owner of the registered trademark Afrin ®

PRINCIPAL DISPLAY PANEL

BI-MART

*Compare to the active ingredient in Afrin ®

LONG LASTING

NASAL SPRAY

Oxymetazoline hydrochloride 0.05%

NASAL DECONGESTANT

FAST CONGESTION RELIEF FOR UP TO 12 HOURS

RELIEVES NASAL CONGESTION DUE TO COLDS AND ALLERGIES

1 FL. OZ. (30 mL)

11523-1167

NASAL 
oxymetazoline hydrochloride spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:37835-995
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE0.05 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POVIDONE (UNII: FZ989GH94E)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:37835-995-341 in 1 CARTON05/16/2024
130 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01205/16/2024
Labeler - Bi-Mart (027630078)
Establishment
NameAddressID/FEIBusiness Operations
SEAWAY PHARMA117218785manufacture(37835-995)

Revised: 5/2024
Document Id: 188bbb87-d83f-05bc-e063-6394a90acc8e
Set id: 276e45f8-8c61-4253-aed7-af50df7e1bd7
Version: 1
Effective Time: 20240516
 
Bi-Mart